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Abstract 
Polymyalgia rheumatica (PMR) is relatively common disorder in elderly. 
When the relationship between polymyalgia rheumatica and giant cell 
arteritis (GCA) is weel recognized there is still controversy  about  PMR 
and malignancy. We are presenting a patient with the PMR and 
adenocarcinoma of the sygmoid colon and hypothesize a paraneoplastic 
relationship. 
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Polymyalgia rheumatica (PMR) is clinical syndrome of the midle aged 
and elderly, characterized by pain, stiffness of the shoulder and pelvic 
girdles, elevated sedimentation rate (ESR), and rapid clinical response to 
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small doses of corticosteroids (1). Polymyalgia rheumatica is a common 
inflammatory disease in adults over age 50, particularly in women (2). 
The diagnosis of polymyalgia rheumatica is still based on diagnostic 
criteria because no clear diagnostic test exists. Several clinical diagnostic 
criteria sets have been suggested and recently a European collaborating 
PMR group suggested the Bird 1979 (3) or Hunder 1982 (4) criteria for 
use whenever possible (5). EULAR response criteria for PMR are 
developed too (6). When the relationship between polymyalgia 
rheumatica and giant cell arteritis (GCA) is weel recognized there is still 
controversy  about  PMR and malignancy.  
Case report 
A 75 –yr-old female was reffered to the rheumatology department and 
diagnosis of PMR established according Bird 1979 criteria. She presented 
with pain and stiffness of  her arms and pelvic girdle, morning stiffness 
>1 hours, Sedimentation rate (ESR) 90 mm/h. Other haematology and 
biochemistry tests  were  normal. There was no history of headache, 
visual changes and weight loss. She was treated with prednisolone 15 mg 
in fast reduction manner with the rapid clinical response. ESR after 1 
month droped to 20 mm/h, physical function recovered. She  continue 5 
mg  of prednisolone   during 2 years.  Six months after corticosteroids 
were stoped  she returned with the same symptoms: pain and stiffness in 
both shoulders, pelvic girdle,  general weekness, fatigue and constipation 
The investigation revealed ESR 88 mm/h, CRP 136 mg/dL, erytrocite 
3.81, haemoglobin 11.7g/dL, white blood cell 7.6, Fe 5, UIBC 34, TIBC 
39, repeated  occult blood test was positive. Other haematology and 
biochemistry findings were normal. Chest x-rays was normal. Brest and 
gynecologic examination without patology. Ultrasound finding of 
abdomen shows cholelihiasis. Colonoscopy showed malignoma of the 
sygmoid colon and computed tomography (CT) no affection of the 
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regional lymph nodes. Patohystology (PHD) showed well differentiated 
tumour (DUKES – A) invaded to submucosis. Laparascopic resection of 
the sygmoid colon was performed. She recovered shorthly after surgery, 
she was without rheumatic symptoms, ESR dropped to 20 mm/h, CRP to 
12mg/dL. One year later the patient was  still asymptomatic.  
 
Discussion 
Polymyalgia rheumatica is a relatively common disorder in patients over 
the age of 50. Genetic predisposition, infection and immunological 
abnormalities contribute to the etiology of polymyalgia rheumatica. In the 
past PMR was considered a manifestation of giant cell arteritis (GCA) or 
a variant of elderly-onset rheumatoid arthritis (7). Many infectious causes 
have been suggested for polymyalgia rheumatica and/or giant cell arteritis 
but the results of the investigations are still controversial and it is not yet 
possible to sustain the hypothesis of an infectious cause for polymyalgia 
(8). The  association between HLA-DR4 and HLA-DRB1  and 
polymyalgia rheumatica are contradictory regarding geographic area and 
ethnic bacground (9,10,11). The giant cell arteritis and polymyalgia 
rheumatica have been considerd as closely related conditions that form a 
spectrum of diseases. In a number of patients with typical polymyalgia 
and no symptoms from the cranial arteritis biopsies shown arteritic 
changes in 10-15 % (1). The association of PMR with malignancy is still 
controversial. Several prospective studies have shown that patients with 
classic PMR not have an increased risk of developing malignancy. In 
contrast kidney, lung and colon cancer are found in patients presenting 
wuth atypical PMR (12).To identify  rheumatic syndromes associated 
with cancer is difficult because the malignant tumours may be 
complicated by the rheumatic symptoms and coversely rheumatic 
disorders may be complicated by tumours. Several cases of PMR and 
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malignancy association have not done a true causal relationship 
(13,14,15,16). When polymyalgia rheumatica and malignancy are 
associated by chance or by a paraneoplastic relationship is still 
questionable. In our case after treatment of neoplasia musculoskeletal 
symptoms were completely resolved and we can hypothesize that in our 
patient PMR was a paraneoplastic manifestation. Although generally held 
that an extensive search for occult malignancy is not recommended, if the 
rheumatic disorder is accompanied by findings suggestive malignancy a 
wider screen for searching occult neoplasia is justified (17).  
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